Log In
BCIQ
Print this Print this
 

Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)

BCIQ
Print ChartPrint this
4 - Diagnostic 7 - Cancer 1 - Cancer 1 - Cancer 9 - Cancer 1 - Cancer 1 - Diagnostic 11 - Cancer 1 - Renal 3 - Cancer 24 - Cancer 22 - Cancer 1 - Cancer
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cancer

1

22

24

3

11

1

9

1

1

7

Diagnostic

-

-

-

-

1

-

-

-

-

4

Renal

-

-

-

1

-

-

-

-

-

-




 Products Targeting Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

39

$179,761.0M

$176,770.3M

$2,547.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today